Copperwynd Financial LLC Grows Stock Holdings in CVS Health Corporation (NYSE:CVS)

Copperwynd Financial LLC grew its stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 166.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 12,371 shares of the pharmacy operator's stock after acquiring an additional 7,734 shares during the period. Copperwynd Financial LLC's holdings in CVS Health were worth $838,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Essex Financial Services Inc. boosted its holdings in shares of CVS Health by 0.8% in the 1st quarter. Essex Financial Services Inc. now owns 20,705 shares of the pharmacy operator's stock valued at $1,403,000 after purchasing an additional 166 shares during the last quarter. McIlrath & Eck LLC increased its stake in CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after buying an additional 174 shares during the period. Sumitomo Life Insurance Co. increased its stake in CVS Health by 1.0% during the 1st quarter. Sumitomo Life Insurance Co. now owns 17,114 shares of the pharmacy operator's stock worth $1,159,000 after buying an additional 174 shares during the period. Koshinski Asset Management Inc. increased its position in shares of CVS Health by 3.7% in the 1st quarter. Koshinski Asset Management Inc. now owns 4,930 shares of the pharmacy operator's stock worth $334,000 after purchasing an additional 178 shares during the last quarter. Finally, Horizon Bancorp Inc. IN increased its position in shares of CVS Health by 7.4% in the 1st quarter. Horizon Bancorp Inc. IN now owns 2,610 shares of the pharmacy operator's stock worth $177,000 after purchasing an additional 180 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Guy P. Sansone acquired 1,570 shares of the company's stock in a transaction on Thursday, June 5th. The shares were acquired at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the purchase, the director owned 12,007 shares in the company, valued at approximately $764,845.90. The trade was a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 1.22% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the stock. Robert W. Baird lifted their price target on shares of CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a report on Tuesday, April 15th. UBS Group lifted their price target on shares of CVS Health from $67.00 to $71.00 and gave the company a "neutral" rating in a report on Friday, May 2nd. Wall Street Zen raised shares of CVS Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Wells Fargo & Company reissued an "overweight" rating and set a $84.00 target price (up from $76.00) on shares of CVS Health in a research note on Tuesday, May 6th. Finally, Morgan Stanley reaffirmed an "overweight" rating on shares of CVS Health in a research note on Tuesday, April 15th. Two research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $75.06.

CVS Health Stock Down 0.3%

CVS stock traded down $0.19 during mid-day trading on Monday, hitting $61.77. 4,271,697 shares of the company were exchanged, compared to its average volume of 10,750,419. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.82. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $72.51. The firm has a market cap of $78.14 billion, a P/E ratio of 14.74, a P/E/G ratio of 0.89 and a beta of 0.57. The firm's 50 day simple moving average is $64.70 and its 200 day simple moving average is $63.13.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. The firm had revenue of $94.59 billion during the quarter, compared to analysts' expectations of $93.07 billion. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The company's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.31 earnings per share. On average, sell-side analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 1st. Shareholders of record on Tuesday, July 22nd will be issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.31%. The ex-dividend date is Tuesday, July 22nd. CVS Health's payout ratio is 63.48%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.